Press Release Details

Corporate
Henry Schein at a Glance

Press Release Details

Henry Schein Announces Fourth Quarter and Year-End Results

02/29/00
Sales Exceed $2 Billion for 1999; Up 22% in Quarter, 19% for Year

Fourth Quarter Dental Sales Grow Over Prior Year, Solid Gains Across All Other Groups

MELVILLE, N.Y.--(BUSINESS WIRE)--February 29, 2000-- Henry Schein, Inc. (Nasdaq: HSIC) today announced financial results for the 1999 fourth quarter and year.

For the three months ended December 25, 1999, net sales increased 22% to $611 million, from $503 million in the fourth quarter last year. Net income was $15.5 million, compared with adjusted net income of $19.4 million in the fourth quarter of 1998. Diluted earnings per share were $0.38 versus an adjusted $0.46 in the 1998 fourth quarter.

For the year ended December 25, 1999, the Company reported net sales up 19% to $2.3 billion, from $1.9 billion in 1998. Adjusted net income grew to $59.8 million, or $1.44 per diluted share, compared with an adjusted net income of $57.8 million, or $1.39 per diluted share, in the prior year.

Commenting on the quarter, Stanley M. Bergman, Chairman, Chief Executive Officer and President of Henry Schein, Inc., stated, "Fourth quarter sales growth was reported across all business groups and earnings per share for the quarter were consistent with the expectations that we communicated last quarter. In particular, Dental sales of $276.6 million exceeded our expectations, rising 1% over the 1998 fourth quarter and up 7% compared with the 1999 third quarter."

The Company stated that its Medical, Veterinary, Technology and International groups continue to grow at impressive rates, as net sales for those groups combined in the fourth quarter of 1999 were 46% higher than last year, with 9% internally generated.

"Last October we set forth specific initiatives for increasing sales and reducing expenses in our Dental business. I am pleased to report that we have successfully begun to execute our plan. First, we have appointed John Chatham, an industry veteran, as Vice President of Field Sales for Sullivan-Schein Dental(TM), our U.S. Dental business. We have also established a fully-dedicated management team for Sullivan-Schein Dental's equipment business with the mission of improving customer service and increasing sales and profitability.

"We have begun to implement our rightsizing plan for the Dental business, which we expect to complete by the end of 2000. Once the plan is fully implemented, we anticipate annual savings of at least $4 million to $6 million. As a result of one-time costs necessary to implement the plan during the current year, we do not expect to see meaningful savings until 2001," said Mr. Bergman. "This expected savings is in addition to the approximately $2 million of incremental costs saved as a result of our decision to cancel the opening of another distribution center, as previously announced."

The Company noted that Michael Racioppi, previously interim President of Henry Schein's Medical Group, has been appointed President. The Medical Group reported a 47% increase in sales compared to last year, of which 12% was internally generated.

"Michael has demonstrated exceptional leadership qualities during his eight-year tenure at Henry Schein," said Mr. Bergman. "I am confident in his ability to continue to increase sales and profitability in our Medical Group."

Mr. Bergman continued, "We are very excited about the success of our e-commerce business, which continued its trend of exceptional growth during the quarter. Sales processed through our ArubA(TM) e-commerce suite of systems more than doubled from the fourth quarter of 1998, reaching an annual run rate of well over $200 million. We are putting additional resources behind this effort and expect to announce additional strategic initiatives in the near-term that will further our Internet presence."

Mr. Bergman concluded, "While 1999 was not without challenge, we ended the year with determination and confidence in our ability to grow sales and grow earnings in the year ahead."

Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners, including dental practices and laboratories, physician practices and veterinary clinics. The Company, recognized for its excellent customer service and low prices, serves more than 300,000 customers worldwide.

Headquartered in Melville, New York, the Company employs over 6,000 people in 16 countries. Sales in 1999 were $2.3 billion. For more information, visit the Henry Schein website at http://www.henryschein.com.

Certain information contained herein includes information that is forward-looking. The matters referred to in forward-looking statements may be affected by the risks and uncertainties involved in the Company's business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in the Company's Securities and Exchange Commission filings.

                                       (TABLES TO FOLLOW)



                  HENRY SCHEIN, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF OPERATIONS
                 (in thousands, except per share data)

                     Three Months Ended         Twelve Months Ended
                     ------------------         -------------------
                     Dec. 25,   Dec. 26,        Dec. 25,    Dec. 26,
                       1999       1998            1999        1998
                     --------   --------        --------    --------



                    (unaudited)(unaudited)

Net sales         $  611,261  $ 502,717        $ 2,285,700 $ 1,921,685
Cost of sales        424,336    340,882          1,587,344   1,319,861
                  ------------------------     -----------------------

       Gross profit  186,925    161,835            698,356     601,824
Operating expenses:
 Selling, general
  and administrative 155,902    128,356            579,124     505,628
 Merger and
  integration costs        0     24,026             13,467      56,666
                  ------------------------     -----------------------

 Operating income     31,023      9,453            105,765      39,530
Other income (expense):
    Interest income    2,570      2,138              7,777       6,964
    Interest expense (7,027)     (3,494)           (23,593)    (12,050)
    Other - net          481        720               (166)      1,570

                  ------------------------     -----------------------
 Income before taxes on income,
  minority interest and equity in
   earnings (losses)
    of affiliates     26,085      8,817             89,783      36,014
Taxes on income        9,390      7,842             35,589      20,325
Minority interest in net
 income of subsidiaries  418        202              1,690         145
Equity in earnings (losses)
  of affiliates         (738)      (687)            (2,192)        783
                  ------------------------     -----------------------
                  ------------------------     -----------------------
Net income        $   15,539  $      86        $    50,312 $    16,327
                  ========================     =======================

Adjusted net income:
    Net income    $   15,539  $      86        $    50,312 $    16,327
    Adjustments:
     Merger and integration
      costs                0     24,026             13,467      56,666
       Tax effect on merger and
        integration costs  0     (4,756)            (3,983)    (12,591)
       Pro-forma tax adjustment
        - Meer             0          0                  0      (2,579)
                  ------------------------     -----------------------

Adjusted net
 income           $   15,539 $   19,356        $    59,796 $    57,823
                  ========================     =======================

Adjusted net income per common share:
    Basic         $     0.38 $     0.48        $      1.47 $      1.47
                  ========================     =======================
    Diluted       $     0.38 $     0.46        $      1.44 $      1.39
                  ========================     =======================

Weighted average shares:
    Basic             40,703     39,939             40,585      39,305
                  ========================     =======================
    Diluted           41,101     42,058             41,438      41,549
                  ========================     =======================




                  HENRY SCHEIN, INC. AND SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEETS
                   (in thousands, except share data)
                               (audited)


                                       Dec. 25,         Dec. 26,
                                         1999             1998



     ASSETS
Current assets:
    Cash and cash equivalents        $  26,019         $  28,222
    Accounts receivable, less reserves
     of $20,391 and
       $20,136, respectively           388,063           338,121
    Inventories                        285,590           270,008
    Deferred income taxes               15,520            14,532
    Prepaid expenses and other          63,617            53,646
                                        ------            ------
            Total current assets       778,809           704,529
Property and equipment, net of
accumulated depreciation and amortization
 of $60,702 and $53,756, respectively   86,627            67,646

Goodwill and other intangibles, net of accumulated
    amortization of $31,356 and $18,123,
      respectively                     295,113           148,428
Investments and other                   43,553            41,437
                                       -------           --------
                            $        1,204,102    $      962,040


     LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
    Accounts payable        $          198,983    $      169,860
    Bank credit lines                   41,527            19,372
    Accruals:
       Salaries and related expenses    31,188            29,675
       Merger and integration costs     10,093            21,992
       Other                            64,710            50,404
    Current maturities of long-term debt 3,879             9,634


            Total current liabilities  350,380           300,937
Long-term debt                         318,218           180,445
Other liabilities                        9,782            11,720


            Total liabilities          678,380           493,102
                                       -------           -------
Minority interest                        7,855             5,904
                                       -------           -------

Stockholders' equity:
   Common stock, $.01 par value,
    authorized 120,000,000;
      issued and outstanding
      40,768,306 and 40,250,936,
       respectively                        407               402
   Additional paid-in capital          361,757           348,119
   Retained earnings                   167,809           119,064
   Treasury stock, at cost
    (62,479 shares)                     (1,156)           (1,156)
   Accumulated comprehensive income    (10,359)           (2,057)
   Deferred compensation                  (591)           (1,338)


            Total stockholders' equity 517,867           463,034
                                       -------           -------
                             $       1,204,102    $      962,040
                                     =========           =======
*T


    CONTACT:  Henry Schein, Inc.
              Steven Paladino
              Executive Vice President and
              Chief Financial Officer
              (516) 843-5500
                        or
              Susan Vassallo
              Manager, Investor and
              Public Relations
              (516) 843-5562
              svassa@henryschein.com